aTyr Pharma, Inc. (NASDAQ:ATYR) Receives $20.20 Consensus Target Price from Brokerages
Shares of aTyr Pharma, Inc. (NASDAQ:ATYR – Get Free Report) have been given an average rating of “Buy” by the seven research firms that are covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target […]
Shares of aTyr Pharma, Inc. (NASDAQ:ATYR – Get Free Report) have been given an average rating of “Buy” by the seven research firms that are covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target […]
